BEGIN:VCALENDAR
VERSION:2.0
METHOD:PUBLISH
PRODID:-//Telerik Inc.//Sitefinity CMS 15.4//EN
BEGIN:VTIMEZONE
TZID:Central Standard Time
BEGIN:STANDARD
DTSTART:20251102T020000
RRULE:FREQ=YEARLY;BYDAY=1SU;BYHOUR=2;BYMINUTE=0;BYMONTH=11
TZNAME:Central Standard Time
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
END:STANDARD
BEGIN:DAYLIGHT
DTSTART:20250301T020000
RRULE:FREQ=YEARLY;BYDAY=2SU;BYHOUR=2;BYMINUTE=0;BYMONTH=3
TZNAME:Central Daylight Time
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
END:DAYLIGHT
END:VTIMEZONE
BEGIN:VEVENT
DESCRIPTION:Thursday\, September 4\, 202512:00pm - 1:00pmHybrid Attendance:
  Research Bldg. 6\, 1.206 Auditoriumor Zoomhttps://www.zoomgov.com/s/16090
 39203?pwd=ZGILbiLGtdLuMnWgX9TrdHhw06tyb2.1passcode: 089555&nbsp\;Guest Pre
 senterMaurice Willis\, MD\, FACPDivision ChiefProfessor\, Division of Medi
 cal OncologyProfessor of Internal Medicine"The Neutropenic Fever that Bit 
 Me"Objectives: At this conclusion of this presentation\, participants shou
 ld be able to:Be aware of basic Mechanism of Action of some of the newer o
 ncology drugs.How to differentiate the newer side effects from other known
  chemotherapy side effects.How to treat these side effects before consult 
 Oncology.Knowing why one needs to consult Oncology on every one of these p
 atients.&nbsp\;Target Audience and Needs: Internal Medicine faculty\, staf
 f\, registered nurses\, residents\, fellows\, students\, and internists sp
 ecializing in Allergy &amp\; Immunology\, Cardiology\, Endocrinology\, Gas
 troenterology\, General Medicine\,\n    Geriatrics\, Hematology &amp\; Onc
 ology\, Infectious Diseases\, Nephrology\, Palliative Care\, Pulmonary Cri
 tical Care &amp\; Sleep Medicine\, and Rheumatology need to be regularly u
 pdated with new research and guidelines regarding the evaluation\n    and 
 management of medical disorders and implement them in clinical practice to
  enhance the quality of patient care and improve patient outcomes.Educatio
 nal Methods: Educational methods will include lectures\, case presentation
 s\, literature review\, and panel discussion.Activity Evaluation: Particip
 ants may be asked to complete a session evaluation.Financial Disclosure: T
 he following are reports of relationships with commercial interests by tho
 se individuals who are in the position to control the content of this acti
 vity.Dr. Willis discloses the following commercial interests: Lilly (speak
 er). Any potential conflicts for this presentation have been resolved\, an
 d the speaker attests that the clinical recommendations within this presen
 tation are evidence-based and free of\ncommercial bias (e.g.\, peer-review
 ed literature\, adhering to evidence-based practice guidelines).&nbsp\;Acc
 reditation/Credit Designation: The University of Texas Medical Branch is a
 ccredited by the Accreditation Council for Continuing Medical Education (A
 CCME) to provide continuing medical education for physicians.The Universit
 y of Texas Medical Branch designates this live activity for a maximum of _
 1_ AMA PRA Category 1 Credits&trade\;. Physicians should claim only the cr
 edit commensurate with the extent of their participation in the activity.
DTEND:20250911T180000Z
DTSTAMP:20260818T024644Z
DTSTART:20250911T170000Z
LOCATION:
SEQUENCE:0
SUMMARY:Grand Rounds - 09/11/2025
UID:RFCALITEM639226000041057040
X-ALT-DESC;FMTTYPE=text/html:<p style="text-align:center\;"><strong>Thursda
 y\, September 4\, 2025</strong><br /><strong>12:00pm - 1:00pm</strong><br 
 /><br /><strong style="color:#da1f12\;">Hybrid Attendance: Research Bldg. 
 6\, 1.206 Auditorium<br />or </strong><br /><strong style="color:#da1f12\;
 ">Zoom</strong><strong><br /></strong></p><p style="text-align:center\;"><
 a href="https://www.zoomgov.com/s/1609039203?pwd=ZGILbiLGtdLuMnWgX9TrdHhw0
 6tyb2.1">https://www.zoomgov.com/s/1609039203?pwd=ZGILbiLGtdLuMnWgX9TrdHhw
 06tyb2.1</a></p><p style="text-align:center\;">passcode: 089555</p><p styl
 e="text-align:center\;"><strong>&nbsp\;</strong></p><p style="text-align:c
 enter\;"><strong>Guest Presenter</strong></p><p style="text-align:center\;
 font-size:large\;"><strong>Maurice Willis\, MD\, FACP</strong><br /><span 
 style="font-size:medium\;">Division Chief</span><em><span style="font-size
 :medium\;"><br /></span></em><span style="font-size:medium\;">Professor\, 
 Division of Medical Oncology<br />Professor of Internal Medicine</span><em
 ><span style="font-size:medium\;"><br /><br /></span></em></p><p style="te
 xt-align:center\;font-size:large\;"><strong>"The Neutropenic Fever that Bi
 t Me"</strong></p><p style="text-align:left\;"><strong>Objectives:</strong
 > At this conclusion of this presentation\, participants should be able to
 :</p><ol style="text-align:center\;"><li style="text-align:left\;">Be awar
 e of basic Mechanism of Action of some of the newer oncology drugs.</li><l
 i style="text-align:left\;">How to differentiate the newer side effects fr
 om other known chemotherapy side effects.</li><li style="text-align:left\;
 ">How to treat these side effects before consult Oncology.</li><li style="
 text-align:left\;">Knowing why one needs to consult Oncology on every one 
 of these patients.</li></ol><p>&nbsp\;</p><p style="text-align:left\;"><st
 rong>Target Audience and Needs: </strong>Internal Medicine faculty\, staff
 \, registered nurses\, residents\, fellows\, students\, and internists spe
 cializing in Allergy &amp\; Immunology\, Cardiology\, Endocrinology\, Gast
 roenterology\, General Medicine\,\n    Geriatrics\, Hematology &amp\; Onco
 logy\, Infectious Diseases\, Nephrology\, Palliative Care\, Pulmonary Crit
 ical Care &amp\; Sleep Medicine\, and Rheumatology need to be regularly up
 dated with new research and guidelines regarding the evaluation\n    and m
 anagement of medical disorders and implement them in clinical practice to 
 enhance the quality of patient care and improve patient outcomes.</p><p st
 yle="text-align:left\;"><strong>Educational Methods: </strong>Educational 
 methods will include lectures\, case presentations\, literature review\, a
 nd panel discussion.</p><p style="text-align:left\;"><strong>Activity Eval
 uation: </strong>Participants may be asked to complete a session evaluatio
 n.</p><p style="text-align:left\;"><strong>Financial Disclosure: </strong>
 The following are reports of relationships with commercial interests by th
 ose individuals who are in the position to control the content of this act
 ivity.</p><p style="text-align:center\;"><strong>Dr. Willis discloses the 
 following commercial interests: Lilly (speaker). Any potential conflicts f
 or this presentation have been resolved\, and the speaker attests that the
  clinical recommendations within this presentation are evidence-based and 
 free of\ncommercial bias (e.g.\, peer-reviewed literature\, adhering to ev
 idence-based practice guidelines).</strong></p><p style="text-align:center
 \;"><strong>&nbsp\;</strong></p><strong></strong><p style="text-align:left
 \;"><small>Accreditation/Credit Designation: </small><small>The University
  of Texas Medical Branch is accredited by the Accreditation Council for Co
 ntinuing Medical Education (ACCME) to provide continuing medical education
  for physicians.</small></p><small></small><p style="text-align:left\;"><s
 mall>The University of Texas Medical Branch designates this live activity 
 for a maximum of _1_ AMA PRA Category 1 Credits&trade\;. Physicians should
  claim only the credit commensurate with the extent of their participation
  in the activity.</small></p><strong></strong>
END:VEVENT
END:VCALENDAR